Agensys Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $537M

  • Investors
  • 1

Agensys General Information

Description

Developer of therapeutic human monoclonal antibodies and antibody-drug conjugates for the treatment of cancer. The company develops products to treat various tumors, as well as prostate, kidney, bladder, lung, and colon cancers, thereby enabling patients with treatment for cancers.

Contact Information

Website
www.agensys.com
Formerly Known As
UroGenesys
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2225 Colorado Avenue
  • Santa Monica, CA 90404
  • United States
+1 (310)
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • 2225 Colorado Avenue
  • Santa Monica, CA 90404
  • United States
+1 (310)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Agensys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 18-Dec-2007 $537M Completed Clinical Trials - Phase 2
5. Later Stage VC (Series D) 12-Jul-2007 Completed Clinical Trials - Phase 1
4. Later Stage VC (Series C) 05-Mar-2002 Completed Clinical Trials - Phase 1
3. Early Stage VC (Series B) 01-Nov-1999 Completed Clinical Trials - Phase 1
2. Early Stage VC (Series A) 10-Nov-1997 $8M $8M Completed Product Development
1. University Spin-Out 01-Jan-1996 Completed Startup
To view Agensys’s complete valuation and funding history, request access »

Agensys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutic human monoclonal antibodies and antibody-drug conjugates for the treatment of cancer. The compa
Drug Delivery
Santa Monica, CA

Alameda, CA
 

Bothell, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Agensys Competitors (20)

One of Agensys’s 20 competitors is Exelixis, a Formerly VC-backed company based in Alameda, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Exelixis Formerly VC-backed Alameda, CA
Seagen Formerly VC-backed Bothell, WA
Sutro Biopharma Formerly VC-backed South San Francisco, CA
Amgen Formerly PE-Backed Thousand Oaks, CA
Helsinn Healthcare Corporation Lugano, Switzerland
You’re viewing 5 of 20 competitors. Get the full list »

Agensys Patents

Agensys Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024344898-A1 Treating locally advanced or metastatic urothelial cancer with anti-191p4d12 antibody drug conjugates in combination with pembrolizumab Pending 21-Sep-2023
EP-4780498-A1 Treating locally advanced or metastatic urothelial cancer with anti-191p4d12 antibody drug conjugates in combination with pembrolizumab Pending 21-Sep-2023
WO-2025064741-A1 Treating locally advanced or metastatic urothelial cancer with anti-191p4d12 antibody drug conjugates in combination with pembrolizumab Inactive 21-Sep-2023
WO-2024129554-A3 Combination therapy Inactive 16-Dec-2022
WO-2024129552-A2 Combination therapy of a pd-1 antagonist, a lag3 antagonist and an antibody drug conjugate that binds 191p4d12 protein for treating patients with cancer Inactive 16-Dec-2022 C07K16/2803
To view Agensys’s complete patent history, request access »

Agensys Former Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alta Partners Venture Capital Minority
Bear Stearns Health InnoVentures Management Venture Capital Minority
Bellco Capital PE/Buyout Minority
Carnegie Investment Counsel Asset Manager Minority
Duquesne Light Corporation Minority
You’re viewing 5 of 15 investors. Get the full list »

Agensys Investments (1)

Agensys’s most recent deal was a Corporate Asset Purchase with Agensys (160,000 square foot site). The deal was made on 11-Jan-2011.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Agensys (160,000 square foot site) 11-Jan-2011 Corporate Asset Purchase Buildings and Property
To view Agensys’s complete investments history, request access »

Agensys FAQs

  • When was Agensys founded?

    Agensys was founded in 1996.

  • Where is Agensys headquartered?

    Agensys is headquartered in Santa Monica, CA.

  • What industry is Agensys in?

    Agensys’s primary industry is Drug Delivery.

  • Is Agensys a private or public company?

    Agensys is a Private company.

  • What is the current valuation of Agensys?

    The current valuation of Agensys is .

  • What is Agensys’s current revenue?

    The current revenue for Agensys is .

  • How much funding has Agensys raised over time?

    Agensys has raised $103M.

  • Who are Agensys’s investors?

    Alta Partners, Bear Stearns Health InnoVentures Management, Bellco Capital, Carnegie Investment Counsel, and Duquesne Light are 5 of 15 investors who have invested in Agensys.

  • Who are Agensys’s competitors?

    Exelixis, Seagen, Sutro Biopharma, Amgen, and Helsinn Healthcare are some of the 20 competitors of Agensys.

  • When was Agensys acquired?

    Agensys was acquired on 18-Dec-2007.

  • Who acquired Agensys?

    Agensys was acquired by Astellas Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process